Alliancebernstein L.P. Sells 30 Shares of Steris Plc (NYSE:STE)
Alliancebernstein L.P. reduced its stake in shares of Steris Plc (NYSE:STE) by 0.5% during the first quarter, Holdings Channel reports. The institutional investor owned 5,811 shares of the medical equipment provider’s stock after selling 30 shares during the period. Alliancebernstein L.P.’s holdings in Steris Plc were worth $404,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Teachers Advisors LLC increased its position in Steris Plc by 9.1% in the fourth quarter. Teachers Advisors LLC now owns 200,351 shares of the medical equipment provider’s stock valued at $13,502,000 after buying an additional 16,717 shares during the period. CENTRAL TRUST Co raised its stake in shares of Steris Plc by 1.3% in the first quarter. CENTRAL TRUST Co now owns 3,670 shares of the medical equipment provider’s stock valued at $255,000 after buying an additional 47 shares in the last quarter. Raymond James Trust N.A. raised its stake in shares of Steris Plc by 1.3% in the first quarter. Raymond James Trust N.A. now owns 5,473 shares of the medical equipment provider’s stock valued at $380,000 after buying an additional 71 shares in the last quarter. Private Trust Co. NA purchased a new stake in shares of Steris Plc during the first quarter valued at approximately $485,000. Finally, Louisiana State Employees Retirement System raised its stake in shares of Steris Plc by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 21,400 shares of the medical equipment provider’s stock valued at $1,486,000 after buying an additional 300 shares in the last quarter. Institutional investors and hedge funds own 91.80% of the company’s stock.
Steris Plc (STE) traded up 0.63% during midday trading on Friday, hitting $85.17. The stock had a trading volume of 32,667 shares. The stock has a market cap of $7.26 billion, a P/E ratio of 60.92 and a beta of 1.33. The company’s 50-day moving average price is $82.49 and its 200 day moving average price is $74.96. Steris Plc has a 12-month low of $63.80 and a 12-month high of $87.49.
Steris Plc (NYSE:STE) last announced its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. Steris Plc had a return on equity of 11.39% and a net margin of 4.63%. The company had revenue of $608 million during the quarter, compared to analysts’ expectations of $597.66 million. During the same quarter in the previous year, the firm earned $0.79 earnings per share. The business’s quarterly revenue was down 4.8% compared to the same quarter last year. On average, equities research analysts predict that Steris Plc will post $4.06 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be given a $0.31 dividend. The ex-dividend date of this dividend is Friday, August 25th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.47%. This is a boost from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s payout ratio is currently 80.00%.
Several equities research analysts have commented on the company. Raymond James Financial, Inc. upped their price target on Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday. BidaskClub lowered Steris Plc from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Zacks Investment Research upgraded Steris Plc from a “sell” rating to a “hold” rating in a research note on Friday, June 23rd. KeyCorp upgraded Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 price target for the company in a research note on Wednesday, May 3rd. Finally, Wellington Shields lowered Steris Plc from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $86.75.
In other Steris Plc news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the business’s stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $80.05, for a total value of $800,500.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Daniel A. Carestio sold 4,745 shares of the business’s stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $80.08, for a total value of $379,979.60. The disclosure for this sale can be found here. Insiders sold 30,340 shares of company stock valued at $2,432,704 in the last ninety days. Insiders own 2.55% of the company’s stock.
Steris Plc Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Plc (NYSE:STE).
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.